HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiac sympathetic neurons provide trophic signal to the heart via β2-adrenoceptor-dependent regulation of proteolysis.

AbstractAIMS:
Increased cardiac sympathetic neuron (SN) activity has been associated with pathologies such as heart failure and hypertrophy, suggesting that cardiac innervation regulates cardiomyocyte trophism. Whether continuous input from the SNs is required for the maintenance of the cardiomyocyte size has not been determined thus far.
METHODS AND RESULTS:
To address the role of cardiac innervation in cardiomyocyte size regulation, we monitored the effect of pharmacological sympathetic denervation in mice on cardiac structure, function, and signalling from 24 h to 30 days in the absence of other pathological stimuli. SN ablation caused an immediate reduction in the cardiomyocyte size with minimal consequences on the resting contractile function. Atrophic remodelling was mediated by the ubiquitin-proteasome system through FOXO-dependent early induction of the muscle-specific E3 ubiquitin ligases Atrogin-1/MAFbx and MuRF1, which was followed by activation of the autophagy-lysosome system. MuRF1 was found to be determinant in denervation atrophy as remodelling did not develop in denervated MuRF1 knock-out (KO) hearts. These effects were caused by decreased basal stimulation of cardiomyocyte β2-adrenoceptor (AR), as atrophy was prevented by treatment of denervated mice with the β2-AR agonist clenbuterol. Consistent with these data, we also observed that β2-AR KO mice showed cardiac atrophy at rest.
CONCLUSION:
Cardiac SNs are strong regulators of the cardiomyocyte size via β2-AR-dependent repression of proteolysis, demonstrating that the neuro-cardiac axis operates constitutively for the determination of the physiological cardiomyocyte size. These results are of great clinical relevance given the role of β-AR in cardiovascular diseases and their modulation in therapy.
AuthorsTania Zaglia, Giulia Milan, Mauro Franzoso, Enrico Bertaggia, Nicola Pianca, Eleonora Piasentini, Vanessa A Voltarelli, David Chiavegato, Patricia C Brum, David J Glass, Stefano Schiaffino, Marco Sandri, Marco Mongillo
JournalCardiovascular research (Cardiovasc Res) Vol. 97 Issue 2 Pg. 240-50 (Feb 01 2013) ISSN: 1755-3245 [Electronic] England
PMID23090606 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Foxo1 protein, mouse
  • Muscle Proteins
  • Proteins
  • Receptors, Adrenergic, beta-2
  • Tripartite Motif Proteins
  • Fbxo32 protein, mouse
  • SKP Cullin F-Box Protein Ligases
  • Trim63 protein, mouse
  • Ubiquitin-Protein Ligases
  • Norepinephrine
Topics
  • Animals
  • Atrophy
  • Autophagy
  • Cells, Cultured
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors (physiology)
  • Heart (innervation)
  • Mice
  • Mice, Inbred C57BL
  • Muscle Proteins (physiology)
  • Myocytes, Cardiac (pathology)
  • Norepinephrine (pharmacology)
  • Proteins (metabolism)
  • Receptors, Adrenergic, beta-2 (physiology)
  • SKP Cullin F-Box Protein Ligases (physiology)
  • Sympathetic Nervous System (physiology)
  • Tripartite Motif Proteins
  • Ubiquitin-Protein Ligases (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: